The Kynurenine Metabolite 3-Hydroxykynurenine is Associated With Risk of Heart Failure in Patients With Predominantly Stable Coronary Artery Disease.

Lund A, Nordrehaug JE, Flo KC, Toresen KH, Alsing C, McCann A, Ueland PM, Nygård O, Giil LM

Open source

DOI
10.1177/11786469261479281
Published
2026
Container
International journal of tryptophan research : IJTR
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/11786469261479281,
  title = {The Kynurenine Metabolite 3-Hydroxykynurenine is Associated With Risk of Heart Failure in Patients With Predominantly Stable Coronary Artery Disease.},
  author = {Lund A and Nordrehaug JE and Flo KC and Toresen KH and Alsing C and McCann A and Ueland PM and Nygård O and Giil LM},
  year = {2026},
  journal = {International journal of tryptophan research : IJTR},
  doi = {10.1177/11786469261479281},
  url = {https://doi.org/10.1177/11786469261479281}
}

RIS

TY  - JOUR
TI  - The Kynurenine Metabolite 3-Hydroxykynurenine is Associated With Risk of Heart Failure in Patients With Predominantly Stable Coronary Artery Disease.
AU  - Lund A
AU  - Nordrehaug JE
AU  - Flo KC
AU  - Toresen KH
AU  - Alsing C
AU  - McCann A
AU  - Ueland PM
AU  - Nygård O
AU  - Giil LM
PY  - 2026
JO  - International journal of tryptophan research : IJTR
DO  - 10.1177/11786469261479281
UR  - https://doi.org/10.1177/11786469261479281
ER  - 

APA

A, L., JE, N., KC, F., KH, T., C, A., A, M., PM, U., O, N., & LM, G. (2026). The Kynurenine Metabolite 3-Hydroxykynurenine is Associated With Risk of Heart Failure in Patients With Predominantly Stable Coronary Artery Disease.. International journal of tryptophan research : IJTR. https://doi.org/10.1177/11786469261479281

Source records